Liver-To-Plasma Vaniprevir (MK-7009) Concentration Ratios in HCV-infected Patients

Antiviral Therapy - United Kingdom
doi 10.3851/imp2958
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Medical Press

Related search

Current Possibilities to Assess the Degree of Liver Fibrosis in Patients With Haemophilia Infected With HCV - Review

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Differential Metabonomic Profiles of Primary Hepatocellular Carcinoma Tumors From Alcoholic Liver Disease, HBV-infected, and HCV-infected Cirrhotic Patients

Oncotarget
Oncology
2017English

Stability of Liver Fibrosis Among HCV-infected Injection Drug Users

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Liver Disease Progression in HIV/HCV Co-Infected Patients: A Role for Metalloproteinases and Their Specific Inhibitors

Retrovirology
VirologyInfectious Diseases
2006English

Synthesis of HCV Protease Inhibitor MK-6325

Synfacts
2015English

Detection of HCV Core Protein in the Nuclei of Different Cell Types and in the Extracellular Matrix in Liver Biopsies From HCV-infected Patients

Microscopy and Microanalysis
Instrumentation
2003English

HCV Genotyping From NGS Short Reads and Its Application in Genotype Detection From HCV Mixed Infected Plasma

PLoS ONE
Multidisciplinary
2015English

Dynamic Analysis of Th1/Th2 Cytokine Concentration During Antiretroviral Therapy of HIV-1/HCV Co-Infected Patients

BMC Infectious Diseases
Infectious Diseases
2012English

Seeking Markers to Distinguish HCV-Infected-autoimmune Subjects From Uninfected-Autoimmune Patients

Russian Open Medical Journal
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy